RBC Life Sciences, Inc.
RBCL
$0.0001
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -559.50K | -1.01M | -774.80K | -602.70K | -710.20K |
| Total Depreciation and Amortization | 520.90K | 551.90K | 553.30K | 579.90K | 597.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.83M | -316.90K | -231.30K | -123.00K | -242.50K |
| Change in Net Operating Assets | -1.03M | 197.90K | 415.30K | -461.80K | -1.22M |
| Cash from Operations | -2.90M | -581.00K | -37.60K | -607.80K | -1.58M |
| Capital Expenditure | -383.90K | -475.80K | -808.30K | -1.07M | -1.13M |
| Sale of Property, Plant, and Equipment | 4.82M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.50K | 0.00 | 0.00 | 0.00 | -40.50K |
| Cash from Investing | 4.48M | -475.80K | -808.30K | -1.07M | -1.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.19M | -220.70K | -216.50K | -212.50K | -208.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.19M | -220.70K | -216.50K | -212.50K | -208.50K |
| Foreign Exchange rate Adjustments | 311.80K | 79.50K | 53.60K | 70.30K | 18.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 693.00K | -1.20M | -1.01M | -1.82M | -2.93M |
